Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection
© 2024 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd..
Hepatitis C virus (HCV)-associated diffuse large B-cell lymphoma (DLBCL) displays peculiar clinicopathological characteristics, but its molecular landscape is not fully elucidated. In this study, we investigated the clinicopathological and molecular features of 54 patients with HCV-associated DLBCL. The median age was 71 years. An underlying marginal zone lymphoma component was detected in 14.8% of cases. FISH analysis showed rearrangements involving BCL6 in 50.9% of cases, MYC in 11.3% and BCL2 in 3.7%. Lymph2Cx-based assay was successful in 38 cases, recognizing 16 cases (42.1%) as ABC and 16 cases as GCB subtypes, while six resulted unclassified. ABC cases exhibited a higher lymphoma-related mortality (LRM). Next-generation sequencing analysis showed mutations in 158/184 evaluated genes. The most frequently mutated genes were KMT2D (42.6%), SETD1B (33.3%), RERE (29.4%), FAS and PIM1 (27.8%) and TBL1XR1 (25.9%). A mutation in the NOTCH pathway was detected in 25.9% of cases and was associated with worst LRM. Cluster analysis by LymphGen classified 29/54 cases within definite groups, including BN2 in 14 (48.2%), ST2 in seven (24.2%) and MCD and EZB in four each (13.8%). Overall, these results indicate a preferential marginal zone origin for a consistent subgroup of HCV-associated DLBCL cases and suggest potential implications for molecularly targeted therapies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
British journal of haematology - (2024) vom: 05. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sciarra, Roberta [VerfasserIn] |
---|
Links: |
---|
Themen: |
Diffuse large B-cell lymphoma |
---|
Anmerkungen: |
Date Revised 05.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1111/bjh.19378 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369327357 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369327357 | ||
003 | DE-627 | ||
005 | 20240306233457.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240306s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/bjh.19378 |2 doi | |
028 | 5 | 2 | |a pubmed24n1318.xml |
035 | |a (DE-627)NLM369327357 | ||
035 | |a (NLM)38442902 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sciarra, Roberta |e verfasserin |4 aut | |
245 | 1 | 0 | |a Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 05.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. | ||
520 | |a Hepatitis C virus (HCV)-associated diffuse large B-cell lymphoma (DLBCL) displays peculiar clinicopathological characteristics, but its molecular landscape is not fully elucidated. In this study, we investigated the clinicopathological and molecular features of 54 patients with HCV-associated DLBCL. The median age was 71 years. An underlying marginal zone lymphoma component was detected in 14.8% of cases. FISH analysis showed rearrangements involving BCL6 in 50.9% of cases, MYC in 11.3% and BCL2 in 3.7%. Lymph2Cx-based assay was successful in 38 cases, recognizing 16 cases (42.1%) as ABC and 16 cases as GCB subtypes, while six resulted unclassified. ABC cases exhibited a higher lymphoma-related mortality (LRM). Next-generation sequencing analysis showed mutations in 158/184 evaluated genes. The most frequently mutated genes were KMT2D (42.6%), SETD1B (33.3%), RERE (29.4%), FAS and PIM1 (27.8%) and TBL1XR1 (25.9%). A mutation in the NOTCH pathway was detected in 25.9% of cases and was associated with worst LRM. Cluster analysis by LymphGen classified 29/54 cases within definite groups, including BN2 in 14 (48.2%), ST2 in seven (24.2%) and MCD and EZB in four each (13.8%). Overall, these results indicate a preferential marginal zone origin for a consistent subgroup of HCV-associated DLBCL cases and suggest potential implications for molecularly targeted therapies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a NGS | |
650 | 4 | |a Nanostring | |
650 | 4 | |a diffuse large B-cell lymphoma | |
650 | 4 | |a hepatitis C virus | |
700 | 1 | |a Merli, Michele |e verfasserin |4 aut | |
700 | 1 | |a Cristinelli, Caterina |e verfasserin |4 aut | |
700 | 1 | |a Lucioni, Marco |e verfasserin |4 aut | |
700 | 1 | |a Zibellini, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Riboni, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Furlan, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Uccella, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Zerbi, Caterina |e verfasserin |4 aut | |
700 | 1 | |a Bianchi, Benedetta |e verfasserin |4 aut | |
700 | 1 | |a Gotti, Manuel |e verfasserin |4 aut | |
700 | 1 | |a Ferretti, Virginia Valeria |e verfasserin |4 aut | |
700 | 1 | |a Varraso, Chiara |e verfasserin |4 aut | |
700 | 1 | |a Fraticelli, Sara |e verfasserin |4 aut | |
700 | 1 | |a Lazic, Tanja |e verfasserin |4 aut | |
700 | 1 | |a Defrancesco, Irene |e verfasserin |4 aut | |
700 | 1 | |a Mora, Barbara |e verfasserin |4 aut | |
700 | 1 | |a Libera, Laura |e verfasserin |4 aut | |
700 | 1 | |a Mazzacane, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Carpi, Federico |e verfasserin |4 aut | |
700 | 1 | |a Berliner, Martha |e verfasserin |4 aut | |
700 | 1 | |a Neri, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Rizzo, Ettore |e verfasserin |4 aut | |
700 | 1 | |a De Paoli, Federica |e verfasserin |4 aut | |
700 | 1 | |a Sessa, Fausto |e verfasserin |4 aut | |
700 | 1 | |a Passamonti, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Paulli, Marco |e verfasserin |4 aut | |
700 | 1 | |a Arcaini, Luca |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d 1955 |g (2024) vom: 05. März |w (DE-627)NLM000000396 |x 1365-2141 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:05 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjh.19378 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 05 |c 03 |